Display options
Share it on

SSM Popul Health. 2016 Dec;2:587-594. doi: 10.1016/j.ssmph.2016.08.005.

Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study.

SSM - population health

Ruth Link-Gelles, Daniel Westreich, Allison E Aiello, Nong Shang, David J Weber, Corinne Holtzman, Karen Scherzinger, Arthur Reingold, William Schaffner, Lee H Harrison, Jennifer B Rosen, Susan Petit, Monica Farley, Ann Thomas, Jeffrey Eason, Christine Wigen, Meghan Barnes, Ola Thomas, Shelley Zansky, Bernard Beall, Cynthia G Whitney, Matthew R Moore

Affiliations

  1. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C-25, Atlanta, GA 30329, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, 135 Dauer Drive, Chapel Hill, NC 27516, USA.
  2. Department of Epidemiology, University of North Carolina at Chapel Hill, 135 Dauer Drive, Chapel Hill, NC 27516, USA.
  3. Minnesota Department of Health, P.O. Box 64975, St. Paul, MN 55164, USA.
  4. Institute for Public Health, University of New Mexico, Emerging Infections Program, 1601 Randolph SE, Suite 1005, Albuquerque, NM 87106, USA.
  5. California Emerging Infections Program, 360 22nd Street, Suite 750, Oakland, CA 94612, USA.
  6. Department of Preventive Medicine, Vanderbilt University School of Medicine, 1500 21st Avenue South, Suite 2600, Nashville, TN 37212, USA.
  7. Department of International Health, Johns Hopkins Bloomberg School of Public Health, 201 W. Preston Street, Baltimore, MD 21201, USA.
  8. New York City Department of Health and Mental Hygiene, 125 Worth St, New York, NY 10013, USA.
  9. Connecticut Department of Public Health, 410 Capitol Avenue, Hartford, CT 06134, USA.
  10. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA; Infection Disease Section, Medical Specialty Care Service Line, Atlanta VA Medical Center, 1670 Clairmont Road, Station 152, Decatur, GA 30033, USA.
  11. Oregon Public Health Division and Oregon Emerging Infections Program, 800 NE Oregon Street, Suite 772, Portland, OR 97232, USA.
  12. Bureau of Epidemiology, Utah Department of Health, 288 N 1460 W, Salt Lake City, UT 84116, USA.
  13. County of Los Angeles Department of Public Health, 313 N Figueroa St, Los Angeles, CA 90012, USA.
  14. Colorado Emerging Infections Program, 4300 Cherry Creek Drive South, Denver, CO 80246, USA.
  15. New York State Department of Health, Corning Tower, Room 651, Empire State Plaza, Albany, NY 12237, USA.
  16. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C-25, Atlanta, GA 30329, USA.

PMID: 27668279 PMCID: PMC5033249 DOI: 10.1016/j.ssmph.2016.08.005

Abstract

In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the US for prevention of invasive pneumococcal disease in children. Individual-level socioeconomic status (SES) is a potential confounder of the estimated effectiveness of PCV13 and is often controlled for in observational studies using zip code as a proxy. We assessed the utility of zip code matching for control of SES in a post-licensure evaluation of the effectiveness of PCV13 (calculated as [1-matched odds ratio]*100). We used a directed acyclic graph to identify subsets of confounders and collected SES variables from birth certificates, geo-coding, a parent interview, and follow-up with medical providers. Cases tended to be more affluent than eligible controls (for example, 48.3% of cases had private insurance vs. 44.6% of eligible controls), but less affluent than enrolled controls (52.9% of whom had private insurance). Control of confounding subsets, however, did not result in a meaningful change in estimated vaccine effectiveness (original estimate: 85.1%, 95% CI 74.8-91.9%; adjusted estimate: 82.5%, 95% CI 65.6-91.1%). In the context of a post-licensure vaccine effectiveness study, zip code appears to be an adequate, though not perfect, proxy for individual SES.

Keywords: Matched case-control; PCV13; Pneumococcal vaccine; Pneumococcus; Socioeconomic status; Vaccine effectiveness

Conflict of interest statement

Conflicts Dr. Lynfield and Ms. Holtzman report grants from Centers for Disease Control and Prevention, during the conduct of the study. In addition, Dr. Lynfield is an editor for a book on Infectious

References

  1. Ann Epidemiol. 2001 Aug;11(6):395-405 - PubMed
  2. Epidemiology. 2011 Sep;22(5):745 - PubMed
  3. Clin Infect Dis. 2014 May;58(9):1250-7 - PubMed
  4. J Health Soc Behav. 2005 Sep;46(3):274-88 - PubMed
  5. Am J Public Health. 2003 Oct;93(10):1655-71 - PubMed
  6. J Sch Health. 2015 Sep;85(9):578-86 - PubMed
  7. Am J Public Health. 1994 Sep;84(9):1414-20 - PubMed
  8. Am J Public Health. 2010 Oct;100(10):1904-11 - PubMed
  9. Pediatrics. 2010 Feb;125(2):e199-207 - PubMed
  10. Am J Public Health. 1994 Sep;84(9):1486-9 - PubMed
  11. J Obstet Gynecol Neonatal Nurs. 2006 Jan-Feb;35(1):3-12 - PubMed
  12. Pediatrics. 2010 Jul;126(1):e9-17 - PubMed
  13. Am J Clin Nutr. 2006 Jan;83(1):139-45 - PubMed
  14. Public Health Rep. 2001 Sep-Oct;116(5):449-63 - PubMed
  15. MMWR Suppl. 2014 Apr 18;63(1):7-12 - PubMed
  16. Am J Epidemiol. 2013 Apr 1;177(7):656-65 - PubMed
  17. J Gerontol B Psychol Sci Soc Sci. 2005 Oct;60 Spec No 2:27-33 - PubMed
  18. Psychosom Med. 2006 May-Jun;68(3):414-20 - PubMed
  19. Ann Epidemiol. 2015 Aug;25(8):549-55 - PubMed
  20. Lancet Respir Med. 2016 May;4(5):399-406 - PubMed
  21. Paediatr Perinat Epidemiol. 2010 Jan;24(1):102-12 - PubMed
  22. Lancet. 2006 Oct 28;368(9546):1495-502 - PubMed
  23. Hum Vaccin. 2010 Sep 23;6(9):null - PubMed
  24. Ann Epidemiol. 2006 Jan;16(1):1-10 - PubMed
  25. Pediatr Blood Cancer. 2009 May;52(5):644-9 - PubMed
  26. JAMA. 2004 May 12;291(18):2197-203 - PubMed
  27. MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61 - PubMed
  28. Paediatr Perinat Epidemiol. 2009 Jul;23(4):301-9 - PubMed
  29. Am J Epidemiol. 1986 May;123(5):901-4 - PubMed
  30. Int J Health Serv. 2012;42(2):293-322 - PubMed
  31. Annu Rev Public Health. 1992;13:385-98 - PubMed
  32. J Public Health Policy. 2015 Aug;36(3):287-303 - PubMed
  33. Vasc Med. 2015 Oct;20(5):439-46 - PubMed
  34. J Epidemiol Community Health. 2013 Apr;67(4):305-10 - PubMed
  35. Ann N Y Acad Sci. 1999;896:173-88 - PubMed
  36. JAMA. 2005 Dec 14;294(22):2879-88 - PubMed
  37. Pediatrics. 2007 Nov;120(5):e1165-73 - PubMed
  38. J Infect Dis. 2004 May 1;189 Suppl 1:S146-52 - PubMed
  39. Pediatr Infect Dis J. 2014 Feb;33(2):158-64 - PubMed
  40. MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7 - PubMed
  41. Am J Epidemiol. 2007 Nov 1;166(9):1096-104 - PubMed
  42. Epidemiology. 2014 Jul;25(4):473-84 - PubMed
  43. J Natl Med Assoc. 2007 Sep;99(9):1013-23 - PubMed
  44. Epidemiology. 2004 Sep;15(5):615-25 - PubMed
  45. J Infect Dis. 2004 May 1;189 Suppl 1:S108-15 - PubMed
  46. MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5 - PubMed
  47. Am J Public Health. 2005 Feb;95(2):312-23 - PubMed
  48. Epidemiology. 1999 Jan;10(1):37-48 - PubMed
  49. Am J Public Health. 2002 Jul;92(7):1100-2 - PubMed
  50. Vaccine. 2013 May 1;31(19):2324-7 - PubMed
  51. Epidemiol Rev. 2004;26:104-11 - PubMed
  52. Stat Med. 2008 Sep 10;27(20):4107-18 - PubMed

Publication Types

Grant support